newsfilter
← Latest News
PR Newswire·

Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules ...